Redpoint Associates II, LLC
10% Owner

Redpoint Associates II, LLC insider trades: Intermolecular (IMI) stock sales

10% Owner, Intermolecular Last trade May 6, 2019 10 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2009
3
Companies
last trade 2019

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Redpoint Associates II, LLC reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 6, 2019IMI↓ Sell$2.9M
May 6, 2019IMI↓ Sell$66K
Mar 1, 2019IMI↓ Sell$195K
Mar 1, 2019IMI↓ Sell$5K
Dec 7, 2012AWAY↓ Sell$3.0M
Dec 7, 2012AWAY↓ Sell$472K
Aug 22, 2012AWAY↓ Sell$5.7M
Aug 22, 2012AWAY↓ Sell$917K
Jul 31, 2012AWAY↓ Sell$1.0M
Jul 31, 2012AWAY↓ Sell$164K
Mar 7, 2012AWAY↓ Sell$299K
Mar 7, 2012AWAY↓ Sell$48K
Nov 23, 2009FTNT↓ Sell$10.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Redpoint Associates II, LLC's insider trades

Redpoint Associates II, LLC is a 10% owner of Intermolecular (IMI). Since Nov 23, 2009, it has reported no open-market purchases and 13 sales worth $25.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (6 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.